Abstract: . . .  (as low as $8) blood test for a marker of risk called C-reactive protein, when added to cholesterol and other data, provides plenty of information to treat intermediate-risk patients. Scanning "is an important technique, but there is a lot of hype," he says. Write to Ron Winslow at ron.winslow@wsj.com  . . .
. . .  the Cleveland Clinic, argues that a cheaper (as low as $8) blood test for a marker of risk called C-reactive protein, when added to cholesterol and other data, provides plenty of information to treat intermediate-risk patients. Scanning "is an important technique, but there is a lot of hype," he says. Write to Ron Winslow at ron.winslow@wsj.com  . . .
. . .  a cheaper (as low as $8) blood test for a marker of risk called C-reactive protein, when added to cholesterol and other data, provides plenty of information to treat intermediate-risk patients. Scanning "is an important technique, but there is a lot of hype," he says. Write to Ron Winslow at ron.winslow@wsj.com  . . .
. . .  suffered a heart attack at age 52 and whose LDL or bad cholesterol was still a relatively high 138 after treatment with a cholesterol-lowering statin drug. The question was whether to get the LDL lower, Dr. Graham says. Her heart scan turned up calcium levels that put her in the 95th percentile for her age -- indicating higher risk. Her drug dose was increased. . . .
--1531,4,191,1697,7653